StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report published on Tuesday morning. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Stock Performance
NYSE CO opened at $1.20 on Tuesday. Global Cord Blood has a 52-week low of $2.03 and a 52-week high of $5.50. The company has a fifty day moving average of $1.19 and a 200-day moving average of $1.34. The company has a market capitalization of $145.86 million, a P/E ratio of 1.88 and a beta of 0.16.
Global Cord Blood Company Profile
Recommended Stories
- Five stocks we like better than Global Cord Blood
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Sales Breakout Sends This Semiconductor Stock to Record High
- Overbought Stocks Explained: Should You Trade Them?
- Surprise Buying Opportunity on This Dividend Aristocrat
- What Investors Need to Know About Upcoming IPOs
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.